Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies

Neurology

Volumn 48, Issue 2, 1997, Pages 445-449

  Schenone, Angelo ^a   Nobbio, L ^a   Mandich, P ^a   Bellone, E ^a   Abbruzzese, M ^a   Aymar, F ^a   Mancardi, G L ^a   Windebank, A J ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; MYELIN PROTEIN;

ARTICLE; CHROMOSOME 17P; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; NERVE PARALYSIS; NEUROPATHY; PRIORITY JOURNAL; SURAL NERVE;

EID: 0031035514     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.2.445     Document Type: Article

References (19)

1. Snipes GJ, Suter U, Welcher AA, Shooter EM. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 1992;117:225-238.
2. o during de novo myelination and nerve repair. Glia 1993;8:256-264.
3. Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-232.
4. Timmerman V, Nelis E, Van Hul W, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1992;1: 171-175.
5. Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143-151.
6. Madrid R, Bradley WG. The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy). Studies on the formation of the abnormal myelin sheath. J Neurol Sci 1975;25:415-448.
7. Chance PF, Reilly M. Inherited neuropathies. Curr Opin Neurol 1994;7:372-380.
8. Hanemann CO, Stoll G, D'Urso D, et al. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. J Neurosci Res 1994;37:654-659.
9. Yoshikawa H, Nishimura T, Nakatsuji Y, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994;35:445-450.
10. Hanemann CO, Stoll G, Müller HW. PMP22 expression in CMT1a neuropathy. Ann Neurol 1995;37:136.
11. Windebank AJ. Inherited recurrent focal neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders, 1993:1137-1148.
12. Neubauer A, Neubauer B, Liu E. Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of β-interferon gene in chronic myelogenous leukemia. Nucleic Acids Res 1990;18:993-998.
13. Ferre F. Quantitative or semi-quantitative PCR: reality versus myth. PCR Methods Appl 1992;2:1-9.
14. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:5463-5467.
15. Nicholson GA, Valentijn LJ, Cherryson AK, et al. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies [published erratum appears in Nat Genet 1994;7:113]. Nat Genet 1994;6:263-266.
16. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 1995;11:274-280.
17. Welcher AA, Suter U, De Leon M, Snipes GJ, Shooter EM. A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc Natl Acad Sci USA 1991;88:7195-7199.
18. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Müller HW. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J 1995;14:1122-1128.
19. Webster HdeF. Development of peripheral myelinated and unmyelinated nerve fibers. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral neuropathy. Philadelphia: W.B. Saunders, 1975:37-61.